Encompass Health Corporation
EHC
$120.18
$0.770.65%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.29% | 29.46% | 19.39% | 27.27% | 38.94% |
| Total Depreciation and Amortization | 10.06% | 9.38% | 9.21% | 7.14% | 12.21% |
| Total Amortization of Deferred Charges | 2.11% | 2.11% | -2.06% | -2.06% | -2.06% |
| Total Other Non-Cash Items | 21.38% | 30.77% | 2.41% | 7.77% | -7.20% |
| Change in Net Operating Assets | 48.15% | -56.46% | 110.00% | 94.54% | 174.48% |
| Cash from Operations | 22.15% | 17.87% | 12.53% | 28.88% | 20.55% |
| Capital Expenditure | -6.99% | -10.19% | -12.90% | -13.36% | -9.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -174.14% | 45.18% | 89.27% | 97.88% | 84.28% |
| Cash from Investing | -8.53% | -8.38% | -9.42% | -7.37% | -3.39% |
| Total Debt Issued | 5.00% | 18.75% | -57.18% | -75.22% | -34.12% |
| Total Debt Repaid | -118.25% | -105.76% | -8.24% | 51.43% | 74.85% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -558.73% | -426.83% | -336.59% | -276.92% | -61.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.92% | -3.97% | -0.50% | 17.08% | 29.50% |
| Other Financing Activities | 70.36% | 136.20% | 178.45% | 44.88% | -108.33% |
| Cash from Financing | -133.82% | -67.65% | -14.04% | -11.32% | -25.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -193.45% | -62.80% | 55.53% | 127.20% | 248.75% |